Retatrutide's Phase 3 program is called TRIUMPH, and includes multiple trials covering obesity, type 2 diabetes (TRANSCEND-T2D), sleep apnea, osteoarthritis, and cardiovascular outcomes
The price collapse was steep
Reduces pigmentation, dark spots, discoloration, dullness, acne spots
According to a recent meta-analysis, the percentage of people suffering chronic fatigue 12 weeks or more after exposure to COVID-19 was 0.32, whereas cognitive impairment was 0.22 [66]
The medication helps improve insulin sensitivity and fat oxidation, making it easier to shed excess weight
### The $1.5 Billion Inventory Bet Eli Lilly and Company has amassed a staggering $1.5 billion in pre-launch inventory for its experimental oral weight-loss drug, orforglipron